Otsuka Holdings Co., Ltd. (TYO:4578)
Japan
· Delayed Price · Currency is JPY 9,161.00
-172.00 (-1.84%)
At close: Dec 5, 2025
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Japan Revenue | 705.50B | 699.70B |
Log In |
Log In |
Log In | Upgrade
|
| North America Revenue | 1,150.80B | 1,095.10B |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 251.10B | 242.90B |
Log In |
Log In |
Log In | Upgrade
|
| Others Revenue | 294.40B | 292.20B |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Revenue | 1,696.20B | 1,630.20B |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Pharmaceuticals Revenue | 1,696.09B | 1,629.03B |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals Revenue | 561.23B | 557.01B |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products Revenue | 33.92B | 33.75B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Revenue | 110.46B | 110.07B |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Pharmaceuticals Business Profit | 417.76B | 390.61B |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals Business Profit | 62.74B | 64.15B |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products Business Profit | 24.28B | 23.66B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Business Profit | 7.33B | 6.95B |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Business Profit | -56.05B | -54.91B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Pharmaceuticals Segment Profit | 404.44B | 285.11B |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals Segment Profit | 59.12B | 59.78B |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products Segment Profit | 23.57B | 23.00B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Profit | 7.72B | 7.53B |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Segment Profit | -55.44B | -51.85B |
Log In |
Log In |
Log In | Upgrade
|